Gisbert Selke

2.7k total citations
20 papers, 765 citations indexed

About

Gisbert Selke is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gisbert Selke has authored 20 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gisbert Selke's work include Pharmaceutical Economics and Policy (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Pharmaceutical studies and practices (5 papers). Gisbert Selke is often cited by papers focused on Pharmaceutical Economics and Policy (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Pharmaceutical studies and practices (5 papers). Gisbert Selke collaborates with scholars based in Germany, Sweden and United Kingdom. Gisbert Selke's co-authors include Ralf Bender, Christian Günster, P. T. Sawicki, Lars G. Hemkens, S. Gutschmidt, Ulrich Grouven, Livio Garattini, Giovanni Giuliani, Brian Godman and Sebastian Schneeweiß and has published in prestigious journals such as Diabetologia, Frontiers in Pharmacology and British Journal of Clinical Pharmacology.

In The Last Decade

Gisbert Selke

20 papers receiving 726 citations

Peers

Countries citing papers authored by Gisbert Selke

Since Specialization

Citations

This map shows the geographic impact of Gisbert Selke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gisbert Selke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gisbert Selke more than expected).

Fields of papers citing papers by Gisbert Selke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gisbert Selke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gisbert Selke. The network helps show where Gisbert Selke may publish in the future.

Co-authorship network of co-authors of Gisbert Selke

This figure shows the co-authorship network connecting the top 25 collaborators of Gisbert Selke. A scholar is included among the top collaborators of Gisbert Selke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gisbert Selke. Gisbert Selke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Clinical and non-clinical aspects of reimbursement policy for orphan drugs in selected European countries	Frontiers in Pharmacology	Przemysław Holko, Rafał Nowak et al.	2
2	Prescribing of valproate and oral antiepileptics for women of childbearing age and during pregnancy in Germany between 2010 and 2020	Pharmacoepidemiology and Drug Safety	Ingrid Köster, Ingo Meyer et al.	4
3	Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study	Pharmacoepidemiology and Drug Safety	Iva Selke Krulichová, Gisbert Selke et al.	26
4	Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany	European Journal of Clinical Pharmacology	Iva Selke Krulichová, Gisbert Selke et al.	8
5	Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany	Pharmaceuticals	Evelien Moorkens, Arnold G. Vulto et al.	22
6	Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implications	Current Medical Research and Opinion	Iva Selke Krulichová, Gisbert Selke et al.	4
7	Nickel-Titanium Closed-coil Springs. Evaluation of the clinical plateau	Revista de Chimie	Aleš Bezrouk, Iva Selke Krulichová et al.	2
8	Improving the managed introduction of new medicines: sharing experiences to aid authorities across Europe	Expert Review of Pharmacoeconomics & Outcomes Research	Brian Godman, Hanne Bak Pedersen et al.	28
9	Quality Indicators as a Tool in Improving the Introduction of New Medicines	Basic & Clinical Pharmacology & Toxicology	Stephen Campbell, Brian Godman et al.	20
10	Improving the managed entry of new medicines: sharing experiences across Europe	Expert Review of Pharmacoeconomics & Outcomes Research	Brian Godman, Ken Paterson et al.	40
11	Antidementivaverordnungen in Stadt und Land – Ein Vergleich zwischen Ballungszentren und Flächenstaaten in Deutschland	Psychiatrische Praxis	Jens Bohlken, Gisbert Selke et al.	8
12	Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study	Diabetologia	Lars G. Hemkens, Ulrich Grouven et al.	435
13	Patterns and prevalence of antidepressant drug use in the German state of Baden‐Wuerttemberg: a prescription‐based analysis	Pharmacoepidemiology and Drug Safety	Mike Ufer, Olaf Junge et al.	29
14	Schätzung der unter Rofecoxib (Vioxx®) in Deutschland in den Jahren 2001–2004 aufgetretenen kardio- und zerebrovaskulären Ereignisse	Medizinische Klinik	Peter T. Sawicki, Ralf Bender et al.	5
15	Stärkung des Wettbewerbs in der Arzneimittelversorgung zur Steigerung von Konsumentennutzen, Effizienz und Qualität : Gutachten im Auftrag des Bundesministeriums für Gesundheit und Soziale Sicherung (BMGS), 2003	Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG))	Gerd Glaeske, Jürgen Klauber et al.	1
16	Non‐antiarrhythmic drugs prolonging the QT interval:considerable use in seven countries	British Journal of Clinical Pharmacology	Fabrizio De Ponti, Elisabetta Poluzzi et al.	29
17	Innovation im Arzneimittelmarkt		Jürgen Klauber, Gisbert Selke et al.	2
18	What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?	Health Policy	Sebastian Schneeweiß, Oliver Schöffski et al.	34
19	The German experience in reference pricing	Health Policy	Giovanni Giuliani, Gisbert Selke et al.	63
20	Auswirkungen der Arzneimittelfestbeträge		Gisbert Selke et al.	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact